Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer ...

They also obtained smoking cessation treatment, exercise and weight counseling, and pneumonia and flu vaccines, if appropriate. Of the people seen by a lung specialist or asthma/COPD educator ...

According to Research by SNS Insider, Nebulizer Market Growth is Driven by Rising Prevalence of Chronic Respiratory Diseases and Technological Advancements.Austin, Oct. 18, 2024 (GLOBE NEWSWIRE) -- ...

The FDA approved dupilumab today as the first biologic treatment for patients ... of the type 2 inflammation underlying COPD and related conditions, like asthma and atopic dermatitis; it is ...

Mepolizumab significantly reduces exacerbations in patients with asthma and concurrent chronic obstructive pulmonary disease (COPD), with ... the first observed treatment date was considered ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...

Steroid tablets are associated with significant adverse side effects. Short-term use risks sleep disturbance, reflux, ...

its use is restricted within the allergic asthma subtype. The treatment of an already established exacerbation is more straight forward than its prevention. It comprises of oxygenation ...

The Asthma Society of Ireland has warned that over-use of steroid medication may cause more harm than good. A study has shown ...

Full session details can be accessed on the ACAAI website. The poster will be available on the publications page of the Apogee website on October 24.